Literature DB >> 21106831

Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production.

Karim Bordji1, Javier Becerril-Ortega, Olivier Nicole, Alain Buisson.   

Abstract

Calcium is a key mediator controlling essential neuronal functions depending on electrical activity. Altered neuronal calcium homeostasis affects metabolism of amyloid precursor protein (APP), leading to increased production of β-amyloid (Aβ), and contributing to the initiation of Alzheimer's disease (AD). A linkage between excessive glutamate receptor activation and neuronal Aβ release was established, and recent reports suggest that synaptic and extrasynaptic NMDA receptor (NMDAR) activation may have distinct consequences in plasticity, gene regulation, and neuronal death. Here, we report for the first time that prolonged activation of extrasynaptic NMDAR, but not synaptic NMDAR, dramatically increased the neuronal production of Aβ. This effect was preceded by a shift from APP695 to Kunitz protease inhibitory domain (KPI) containing APPs (KPI-APPs), isoforms exhibiting an important amyloidogenic potential. Conversely, after synaptic NMDAR activation, we failed to detect any KPI-APP expression and neuronal Aβ production was not modified. Calcium imaging data showed that intracellular calcium concentration after extrasynaptic NMDAR stimulation was lower than after synaptic activation. This suggests distinct signaling pathways for each pool of receptors. We found that modification of neuronal APP expression pattern triggered by extrasynaptic NMDAR activation was regulated at an alternative splicing level involving calcium-/calmodulin-dependent protein kinase IV, but overall APP expression remained identical. Finally, memantine dose-dependently inhibited extrasynaptic NMDAR-induced KPI-APPs expression as well as neuronal Aβ release. Altogether, these data suggest that a chronic activation of extrasynaptic NMDAR promotes amyloidogenic KPI-APP expression leading to neuronal Aβ release, representing a causal risk factor for developing AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106831      PMCID: PMC6633754          DOI: 10.1523/JNEUROSCI.3021-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

Review 1.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 2.  The Yin and Yang of NMDA receptor signalling.

Authors:  Giles E Hardingham; Hilmar Bading
Journal:  Trends Neurosci       Date:  2003-02       Impact factor: 13.837

3.  APP processing and synaptic function.

Authors:  Flavio Kamenetz; Taisuke Tomita; Helen Hsieh; Guy Seabrook; David Borchelt; Takeshi Iwatsubo; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

4.  A systemic administration of NMDA induces immediate early gene pip92 in the hippocampus.

Authors:  K C Chung; S W Shin; M Yoo; M Y Lee; H W Lee; B K Choe; Y S Ahn
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

5.  The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro.

Authors:  K R Tovar; G L Westbrook
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways.

Authors:  G E Hardingham; Y Fukunaga; H Bading
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

7.  STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase.

Authors:  Hiroshi Tokumitsu; Hiroyuki Inuzuka; Yumi Ishikawa; Masahiko Ikeda; Ikutaro Saji; Ryoji Kobayashi
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

8.  Mobile NMDA receptors at hippocampal synapses.

Authors:  Kenneth R Tovar; Gary L Westbrook
Journal:  Neuron       Date:  2002-04-11       Impact factor: 17.173

Review 9.  Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation.

Authors:  Peter Vanhoutte; Hilmar Bading
Journal:  Curr Opin Neurobiol       Date:  2003-06       Impact factor: 6.627

10.  Amyloid precursor protein mRNA levels in Alzheimer's disease brain.

Authors:  Paul Preece; David J Virley; Moheb Costandi; Robert Coombes; Stephen J Moss; Anne W Mudge; Elena Jazin; Nigel J Cairns
Journal:  Brain Res Mol Brain Res       Date:  2004-03-17
View more
  74 in total

Review 1.  New developments on the role of NMDA receptors in Alzheimer's disease.

Authors:  Roberto Malinow
Journal:  Curr Opin Neurobiol       Date:  2011-09-29       Impact factor: 6.627

Review 2.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  AMPA receptor-dependent, light-evoked D-serine release acts on retinal ganglion cell NMDA receptors.

Authors:  Steve J Sullivan; Robert F Miller
Journal:  J Neurophysiol       Date:  2012-05-16       Impact factor: 2.714

4.  FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing.

Authors:  Jaehong Suh; Alvin Lyckman; Lirong Wang; Elizabeth A Eckman; Suzanne Y Guénette
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

5.  Opposing synaptic regulation of amyloid-β metabolism by NMDA receptors in vivo.

Authors:  Deborah K Verges; Jessica L Restivo; Whitney D Goebel; David M Holtzman; John R Cirrito
Journal:  J Neurosci       Date:  2011-08-03       Impact factor: 6.167

Review 6.  From Molecular Circuit Dysfunction to Disease: Case Studies in Epilepsy, Traumatic Brain Injury, and Alzheimer's Disease.

Authors:  Chris G Dulla; Douglas A Coulter; Jokubas Ziburkus
Journal:  Neuroscientist       Date:  2015-05-06       Impact factor: 7.519

Review 7.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

Review 8.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.

Authors:  Pierre Paoletti; Camilla Bellone; Qiang Zhou
Journal:  Nat Rev Neurosci       Date:  2013-06       Impact factor: 34.870

Review 9.  Organization, control and function of extrasynaptic NMDA receptors.

Authors:  Thomas Papouin; Stéphane H R Oliet
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-10-19       Impact factor: 6.237

10.  Aberrant synaptic input to retinal ganglion cells varies with morphology in a mouse model of retinal degeneration.

Authors:  Christopher W Yee; Abduqodir H Toychiev; Elena Ivanova; Botir T Sagdullaev
Journal:  J Comp Neurol       Date:  2014-08-18       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.